What are the signs of effective MS treatment?

Question

Hello doctor,

I am a female patient with stage 2 multiple sclerosis currently undergoing treatment, and I have several questions about managing my condition. How effective is my current treatment in slowing disease progression, and how long will it take to notice improvements or stabilization in my symptoms? Are there specific side effects or risks associated with my medication that I should monitor closely? What signs of worsening disease or new relapses should I be aware of, and when should I contact you? How often will I need follow-up appointments and tests to assess my response to treatment? Are there any precautions I should take regarding infections, vaccinations, or other health risks?

Additionally, are there lifestyle changes, such as diet, exercise, or stress management, that could complement my treatment and improve my overall well-being? Lastly, are there other treatment options or emerging therapies that I should consider for better disease management at this stage?

Please advise.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concerns and will try to help you.

Here is a detailed overview to address your questions and help you manage your condition effectively:

Effectiveness of current treatment: Most multiple sclerosis (MS) treatments aim to reduce relapses and their severity, as well as slow disease progression by limiting new lesions in the brain or spinal cord. Symptom improvements or stabilization may take three to six months after starting or adjusting therapy. Patience is key, as outcomes vary between individuals.
Side effects and risks to monitor: Common side effects depend on the specific medication. For example, injectable therapies like Interferons and Glatiramer acetate can cause side effects such as flu-like symptoms, injection site reactions, or fatigue. Oral therapies like Dimethyl fumarate and Ponesimod can cause stomach upset, flushing, or elevated liver enzymes. Infusion therapies like Ocrelizumab and Natalizumab can cause infusion reactions, increased infection risk, or rare complications like PML (progressive multifocal leukoencephalopathy). Conditions such as persistent or severe side effects like fever, confusion, or unusual weakness or symptoms suggesting an infection, such as prolonged fever or cough, should be reported early.
Monitoring for worsening disease: Watch for new or worsening symptoms like increased difficulty walking, vision changes, or weakness. Frequent relapses indicate possible suboptimal response to treatment. Therefore, contact your doctor promptly if symptoms interfere with daily activities or if relapses occur close together.
Follow-up appointments and testing: Regular check-ups should be done every three to six months, depending on disease activity. Additionally, MRI (magnetic resonance imaging) scans should be conducted to detect new lesions and track disease progression, along with blood tests to monitor medication safety.
Precautions against infections and vaccinations: Stay up to date with non-live vaccines such as flu, COVID-19, and pneumonia. Additionally, take precautions to avoid infections.
Lifestyle changes to complement treatment: Follow a balanced diet rich in fruits, vegetables, whole grains, and lean proteins. Consider vitamin D supplementation, as low levels may worsen MS. Engage in low-impact exercises (yoga and swimming) to improve strength and flexibility. Stress can exacerbate MS symptoms. Practices like meditation, mindfulness, or therapy can help reduce stress. Apart from this, adequate rest is crucial for managing fatigue.
Emerging therapies and other options: Newer options like Ocrelizumab or Siponimod may provide better control of progression but require careful monitoring. Other emerging therapies like BTK (Bruton tyrosine kinase) Inhibitors are currently in clinical trials, targeting B cells with fewer side effects. Discuss potential switches or trials with your neurologist if current therapies do not meet your goals.

I hope this answers your questions.

Thank you.